Biocryst Pharmaceuticals, Inc. <BCRX.O>: RBC cuts to sector perform from outperform; cuts target price to $11 from $13
BCRX•Related News
ChipMOS to Present at UBS Taiwan Summit 2026
IMOS•
S&P 500, Dow futures attempt recovery ahead of inflation report
SPY•
Taurus Investment Holdings acquires Crossroads Business Park industrial portfolio in Laredo, Texas
XLRE•
Signet Jewelers Limited <SIG.N>: BofA Global Research Raises Price Objective to $115 From $102
SIG•
Sinopec files HKEX next-day disclosure return on share repurchase for cancellation
SNP•